Accelerated Growth of Bariatric Surgery With the Introduction of Minimally Invasive Surgery

Nguyen, Ninh T.; Root, Jeffrey; Zainabadi, Kambiz; Sabio, Allen; Chalifoux, Sara; Stevens, C. Melinda; Mavandadi, Shahrzad; Longoria, Mario; Wilson, Samuel E.

doi:10.1001/archsurg.140.12.1198

Cited by 200 publications

(91 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…8 Advances in minimally invasive surgery have shortened recovery time, reduced peri-operative morbidity, and expanded the range of patients amenable to this procedure. 9 While previous studies have demonstrated that marked weight reduction following BAS results in a reduction in LV mass and improved diastolic filling, 10 outcomes of patients with severe systolic heart failure following BAS have not been previously reported. subsequent 12 mo.…”

Section: Introductionmentioning

confidence: 98%

Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure

Ramani

McCloskey

Ramanathan

et al. 2008

Clinical Cardiology

107

View full text Add to dashboard Cite

Background: Morbid obesity (MO) is a risk factor for congestive heart failure (CHF). The presence of MO impairs functional status and disqualifies patients for cardiac transplantation. Bariatric surgery (BAS) is a frontline, durable treatment for MO; however, the safety and efficacy of BAS in advanced CHF is unknown. Hypothesis: We hypothesized that by utilizing a coordinated approach between an experienced surgical team and heart failure specialists, BAS is safe in patients with advanced systolic CHF and results in favorable outcomes. Methods: We performed a retrospective chart review of 12 patients with MO (body mass index [BMI] 53±7 kg/m 2 ) and systolic CHF (left ventricular ejection fraction [LVEF] 22±7%, New York Heart Association [NYHA] class 2.9±0.7) who underwent BAS, and then compared outcomes with 10 matched controls (BMI 47.2±3.6 kg/m 2 , LVEF 24±7%, and NYHA class 2.4±0.7) who were given diet and exercise counseling. Results: At 1 y, hospital readmission in BAS patients was significantly lower than controls (0.4±0.8 versus 2.5±2.6, p = 0.04); LVEF improved significantly in BAS patients (35±15%, p = 0.005), but not in controls (29±14%, p = not significant [NS]). The NYHA class improved in BAS patients (2.3±0.5, p = 0.02), but deteriorated in controls (3.3±0.9, p = 0.02). One BAS patient was successfully transplanted, and another listed for transplantation. Conclusions: Bariatric surgery is safe and effective in patients with MO and severe systolic CHF, and should be considered in patients who have failed conventional therapy to improve clinical status.

show abstract

Section: Introductionmentioning

confidence: 98%

Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure

Ramani

McCloskey

Ramanathan

et al. 2008

Clinical Cardiology

107

View full text Add to dashboard Cite

show abstract

“…In 1994, Wittgrove et al [6] performed the first laparoscopic bypass in Roux-en-Y with the purpose of treating this pathology. This method, over the years, has become one of the most accomplished in the world [7], with about 140,000 procedures performed annually in the USA by the year 2008 [8].…”

Section: Introductionmentioning

confidence: 99%

Approach of the Bile Duct by Gastrostomy in Patients With Bypass in Roux-en-Y Proved to Be Safe and Effective

et al. 2017

View full text Add to dashboard Cite

Background: The prevalence and increase of obesity in the world are that 2.3 billion adults were overweight and 700 million adults were obese in 2015. In the context of the morbid obesity pandemic, bariatric surgery was presented as a gold standard treatment. It is known that the prevalence of cholelithiasis is 3 to 4 times higher in morbidly obese patients when compared to the general population. Literature reports that the first attempts to approach the biliary tract in patients with gastric bypass in Roux-en-Y, were performed transorally and had resulted in low success rates. The aim of this study was to analyze the results of the use of the endoscopic transgastrostomy technique for the treatment of biliary tract diseases in patients submitted to Yde-Roux bypass.

show abstract

“…Therefore, the number of patients undergoing Roux-en-Y gastric bypass (RYGB) surgery has increased by almost tenfold in the past 2 decades, with approximately 101,645 operations performed in 2011 alone [18,19]. However, although RYGB is effective for the vast majority of patients, a small proportion of RYGB patients develop serious nutritional complications, debilitating gastrointestinal (GI) symptoms, and/or fail to reach their weight loss goals [20][21][22][23][24][25].…”

Section: Introductionmentioning

confidence: 99%

Impact of Roux-En-Y Gastric Bypass Surgery on Neurohormonal and Gastrointestinal Physiology: Insights for Future Weight Loss Efforts

Hussan¹,

Ugbarugba²,

Krishna³

et al. 2017

J Obes Weight Loss Ther

View full text Add to dashboard Cite

Roux-en-Y Gastric Bypass (RYGB), is an effective weight loss intervention for patients failing conventional nonsurgical methods. Despite its popularity, only a subset of patients undergo RYGB due to its cumbersome nature. Furthermore, patients may experience nutritional deficiencies or weight regain after RYGB. This review will delineate the less known impact of RYGB on neurohormonal and gastrointestinal physiology involved in weight loss. Understanding these alterations will contribute to the development of future novel investigations targeting viable weight loss strategies.

show abstract

Accelerated Growth of Bariatric Surgery With the Introduction of Minimally Invasive Surgery

Abstract: Hypothesis: An increase in national utilization of bariatric surgery correlates with the dissemination of laparoscopic bariatric surgery.

Cited by 200 publications

References 11 publications

Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure

Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure

Approach of the Bile Duct by Gastrostomy in Patients With Bypass in Roux-en-Y Proved to Be Safe and Effective

Impact of Roux-En-Y Gastric Bypass Surgery on Neurohormonal and Gastrointestinal Physiology: Insights for Future Weight Loss Efforts

Contact Info

Product

Resources

About